Page last updated: 2024-10-25

chlorpropamide and Aura

chlorpropamide has been researched along with Aura in 1 studies

Chlorpropamide: A sulfonylurea hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. (From Martindale, The Extra Pharmacopoeia, 30th ed, p277)
chlorpropamide : An N-sulfonylurea that is urea in which a hydrogen attached to one of the nitrogens is substituted by 4-chlorobenzenesulfonyl group and a hydrogen attached to the other nitrogen is substituted by propyl group. Chlorpropamide is a hypoglycaemic agent used in the treatment of type 2 (non-insulin-dependent) diabetes mellitus not responding to dietary modification.

Research Excerpts

ExcerptRelevanceReference
" The half-life of chlorpropamide was significantly shorter in the patients (34."1.27Pharmacokinetics of chlorpropamide in epileptic patients: effects of enzyme induction and urine pH on chlorpropamide elimination. ( Kärkkäinen, S; Lehtovaara, R; Neuvonen, PJ, 1987)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Neuvonen, PJ1
Kärkkäinen, S1
Lehtovaara, R1

Other Studies

1 other study available for chlorpropamide and Aura

ArticleYear
Pharmacokinetics of chlorpropamide in epileptic patients: effects of enzyme induction and urine pH on chlorpropamide elimination.
    European journal of clinical pharmacology, 1987, Volume: 32, Issue:3

    Topics: Adult; Anticonvulsants; Antipyrine; Chlorpropamide; Enzyme Induction; Epilepsy; Female; Half-Life; H

1987